Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tracheobronchomalacia | 16 | 2023 | 131 | 6.060 |
Why?
|
Thoracic Surgery, Video-Assisted | 9 | 2022 | 273 | 2.520 |
Why?
|
Thoracic Surgical Procedures | 7 | 2023 | 342 | 2.100 |
Why?
|
Trachea | 16 | 2023 | 1076 | 2.040 |
Why?
|
Pulmonary Emphysema | 4 | 2023 | 672 | 1.980 |
Why?
|
Pneumonectomy | 9 | 2023 | 1094 | 1.820 |
Why?
|
Bronchoscopy | 19 | 2023 | 862 | 1.770 |
Why?
|
Surgical Stapling | 2 | 2022 | 97 | 1.470 |
Why?
|
Stents | 15 | 2024 | 3280 | 1.390 |
Why?
|
Bronchi | 10 | 2023 | 840 | 1.300 |
Why?
|
Tracheal Stenosis | 2 | 2021 | 226 | 1.040 |
Why?
|
Prosthesis Implantation | 8 | 2020 | 642 | 1.000 |
Why?
|
Mediastinum | 4 | 2019 | 267 | 0.840 |
Why?
|
Burnout, Professional | 2 | 2021 | 694 | 0.820 |
Why?
|
Lung | 13 | 2023 | 9856 | 0.790 |
Why?
|
Lung Neoplasms | 21 | 2022 | 13102 | 0.760 |
Why?
|
Peptic Ulcer | 1 | 2022 | 223 | 0.750 |
Why?
|
Thymoma | 2 | 2019 | 186 | 0.710 |
Why?
|
Internship and Residency | 7 | 2021 | 5788 | 0.670 |
Why?
|
Thymus Neoplasms | 2 | 2019 | 268 | 0.670 |
Why?
|
Tracheal Diseases | 4 | 2011 | 113 | 0.630 |
Why?
|
Respiratory Function Tests | 5 | 2024 | 1616 | 0.620 |
Why?
|
Parathyroid Neoplasms | 1 | 2019 | 245 | 0.610 |
Why?
|
Silicones | 3 | 2016 | 250 | 0.610 |
Why?
|
Esophageal pH Monitoring | 1 | 2018 | 191 | 0.600 |
Why?
|
Parathyroidectomy | 1 | 2019 | 235 | 0.590 |
Why?
|
Thoracic Surgery | 2 | 2020 | 719 | 0.560 |
Why?
|
Airway Obstruction | 6 | 2023 | 664 | 0.540 |
Why?
|
Bronchial Diseases | 3 | 2011 | 151 | 0.540 |
Why?
|
Quality of Life | 10 | 2024 | 12804 | 0.530 |
Why?
|
Tracheomalacia | 1 | 2016 | 63 | 0.520 |
Why?
|
Thoracotomy | 3 | 2013 | 363 | 0.520 |
Why?
|
Bronchoscopes | 1 | 2015 | 64 | 0.520 |
Why?
|
Respiration Disorders | 2 | 2022 | 371 | 0.500 |
Why?
|
Prostheses and Implants | 5 | 2022 | 1387 | 0.470 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 662 | 0.470 |
Why?
|
Molecular Imaging | 1 | 2020 | 828 | 0.460 |
Why?
|
Gastric Bypass | 1 | 2022 | 812 | 0.450 |
Why?
|
Tomography, X-Ray Computed | 17 | 2020 | 20129 | 0.440 |
Why?
|
Mediastinoscopy | 3 | 2011 | 31 | 0.440 |
Why?
|
Airway Management | 1 | 2016 | 329 | 0.440 |
Why?
|
Absorbable Implants | 2 | 2012 | 342 | 0.430 |
Why?
|
Surgery, Computer-Assisted | 2 | 2019 | 1018 | 0.420 |
Why?
|
Mucocele | 1 | 2012 | 49 | 0.420 |
Why?
|
Esophageal Diseases | 1 | 2012 | 166 | 0.400 |
Why?
|
Tracheotomy | 1 | 2012 | 166 | 0.390 |
Why?
|
Gastroesophageal Reflux | 1 | 2018 | 782 | 0.390 |
Why?
|
Surgical Mesh | 2 | 2011 | 276 | 0.390 |
Why?
|
Suture Techniques | 3 | 2012 | 798 | 0.380 |
Why?
|
Endosonography | 3 | 2018 | 610 | 0.350 |
Why?
|
Tissue Scaffolds | 2 | 2018 | 956 | 0.350 |
Why?
|
Radiography, Thoracic | 1 | 2015 | 1265 | 0.320 |
Why?
|
Retrospective Studies | 33 | 2024 | 77449 | 0.310 |
Why?
|
Esophagectomy | 3 | 2020 | 447 | 0.310 |
Why?
|
Humans | 90 | 2024 | 744343 | 0.310 |
Why?
|
Bronchial Neoplasms | 1 | 2008 | 112 | 0.310 |
Why?
|
Lymph Nodes | 4 | 2018 | 3474 | 0.300 |
Why?
|
Treatment Outcome | 23 | 2024 | 63114 | 0.290 |
Why?
|
Carcinoid Tumor | 1 | 2008 | 235 | 0.280 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2021 | 3047 | 0.280 |
Why?
|
Robotics | 2 | 2013 | 899 | 0.280 |
Why?
|
Respiratory Insufficiency | 3 | 2023 | 1199 | 0.280 |
Why?
|
Hospital Mortality | 2 | 2018 | 5317 | 0.280 |
Why?
|
Lymph Node Excision | 1 | 2012 | 1261 | 0.270 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 2988 | 0.270 |
Why?
|
Aged | 42 | 2020 | 163280 | 0.250 |
Why?
|
Postoperative Complications | 7 | 2023 | 15295 | 0.250 |
Why?
|
Argon Plasma Coagulation | 2 | 2021 | 24 | 0.250 |
Why?
|
Saphenous Vein | 3 | 2002 | 532 | 0.240 |
Why?
|
Male | 57 | 2023 | 350118 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2018 | 5221 | 0.240 |
Why?
|
Models, Animal | 4 | 2020 | 2171 | 0.230 |
Why?
|
Adult | 34 | 2023 | 214055 | 0.220 |
Why?
|
Middle Aged | 41 | 2020 | 213383 | 0.220 |
Why?
|
Polypropylenes | 2 | 2016 | 64 | 0.220 |
Why?
|
Vagotomy, Truncal | 1 | 2022 | 9 | 0.220 |
Why?
|
Neoplasm Staging | 8 | 2020 | 11031 | 0.220 |
Why?
|
Severity of Illness Index | 7 | 2018 | 15540 | 0.210 |
Why?
|
Aged, 80 and over | 22 | 2020 | 57776 | 0.210 |
Why?
|
Hydrogels | 2 | 2018 | 724 | 0.210 |
Why?
|
Female | 49 | 2021 | 380194 | 0.200 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2001 | 72 | 0.200 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 99 | 0.200 |
Why?
|
Tumor Necrosis Factors | 1 | 2021 | 109 | 0.200 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2015 | 332 | 0.190 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 185 | 0.190 |
Why?
|
Biocompatible Materials | 3 | 2018 | 1736 | 0.190 |
Why?
|
Empyema, Pleural | 1 | 2021 | 62 | 0.190 |
Why?
|
Prosthesis Design | 4 | 2016 | 2110 | 0.180 |
Why?
|
Endoscopy | 3 | 2022 | 1785 | 0.180 |
Why?
|
Angioplasty, Balloon | 2 | 2001 | 653 | 0.180 |
Why?
|
Lung Diseases, Parasitic | 1 | 2019 | 14 | 0.180 |
Why?
|
Elastin | 1 | 2021 | 308 | 0.180 |
Why?
|
Formaldehyde | 1 | 2021 | 353 | 0.180 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2019 | 43 | 0.180 |
Why?
|
Deoxyribonucleases | 1 | 2021 | 214 | 0.180 |
Why?
|
Iliac Artery | 1 | 2001 | 364 | 0.170 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2023 | 339 | 0.170 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2002 | 277 | 0.170 |
Why?
|
Pulmonary Atelectasis | 1 | 2020 | 145 | 0.170 |
Why?
|
Peripheral Vascular Diseases | 1 | 2002 | 550 | 0.170 |
Why?
|
General Surgery | 3 | 2021 | 1636 | 0.170 |
Why?
|
Respiratory Tract Fistula | 1 | 2018 | 26 | 0.160 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2016 | 1660 | 0.160 |
Why?
|
Esophageal Neoplasms | 3 | 2020 | 1583 | 0.160 |
Why?
|
Follow-Up Studies | 14 | 2020 | 39050 | 0.160 |
Why?
|
Platelet Aggregation | 1 | 2001 | 798 | 0.160 |
Why?
|
Tropoelastin | 1 | 2017 | 29 | 0.160 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2021 | 1155 | 0.150 |
Why?
|
Adhesives | 1 | 2017 | 61 | 0.150 |
Why?
|
Fiducial Markers | 1 | 2018 | 136 | 0.150 |
Why?
|
Methacrylates | 1 | 2017 | 107 | 0.150 |
Why?
|
Adenosine Triphosphatases | 1 | 2001 | 839 | 0.150 |
Why?
|
Femoral Artery | 1 | 2001 | 845 | 0.150 |
Why?
|
Intraoperative Care | 1 | 2020 | 767 | 0.140 |
Why?
|
Survival Rate | 6 | 2020 | 12788 | 0.140 |
Why?
|
Job Satisfaction | 1 | 2020 | 535 | 0.140 |
Why?
|
Teaching Materials | 1 | 2016 | 86 | 0.140 |
Why?
|
Cell Adhesion | 3 | 2001 | 3144 | 0.140 |
Why?
|
Feasibility Studies | 4 | 2020 | 5078 | 0.140 |
Why?
|
Interleukin-1beta | 1 | 2021 | 972 | 0.130 |
Why?
|
Tissue Adhesives | 1 | 2017 | 179 | 0.130 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2023 | 980 | 0.130 |
Why?
|
Elasticity | 1 | 2017 | 657 | 0.130 |
Why?
|
Gelatin | 1 | 2017 | 225 | 0.130 |
Why?
|
Monocytes | 3 | 2001 | 2596 | 0.130 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 879 | 0.130 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2759 | 0.130 |
Why?
|
Adenocarcinoma | 4 | 2017 | 6364 | 0.130 |
Why?
|
Respiratory System | 1 | 2018 | 557 | 0.130 |
Why?
|
Prognosis | 9 | 2018 | 29063 | 0.130 |
Why?
|
Salvage Therapy | 1 | 2022 | 1275 | 0.130 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 153 | 0.130 |
Why?
|
Thoracic Diseases | 1 | 2016 | 97 | 0.130 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 1995 | 97 | 0.130 |
Why?
|
Electronic Mail | 1 | 2016 | 213 | 0.120 |
Why?
|
Swine | 3 | 2020 | 5917 | 0.120 |
Why?
|
Workload | 1 | 2020 | 850 | 0.120 |
Why?
|
Operating Rooms | 1 | 2021 | 817 | 0.120 |
Why?
|
Radiosurgery | 2 | 2018 | 1329 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 215 | 0.120 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2019 | 451 | 0.120 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2014 | 39 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1107 | 0.120 |
Why?
|
Aorta, Thoracic | 2 | 2010 | 1082 | 0.120 |
Why?
|
Lymphatic Metastasis | 3 | 2012 | 2924 | 0.120 |
Why?
|
Thymus Hyperplasia | 1 | 2013 | 30 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 266 | 0.120 |
Why?
|
Protein Engineering | 1 | 2017 | 540 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.120 |
Why?
|
Sheep | 4 | 2021 | 1437 | 0.120 |
Why?
|
Tracheitis | 1 | 2013 | 28 | 0.120 |
Why?
|
Video-Assisted Surgery | 1 | 2013 | 51 | 0.120 |
Why?
|
Lung Diseases | 2 | 2016 | 1886 | 0.110 |
Why?
|
Corynebacterium | 1 | 2013 | 47 | 0.110 |
Why?
|
Corynebacterium Infections | 1 | 2013 | 27 | 0.110 |
Why?
|
Triage | 1 | 2020 | 976 | 0.110 |
Why?
|
Glucagon | 1 | 1995 | 533 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4554 | 0.110 |
Why?
|
Thymectomy | 1 | 2013 | 191 | 0.110 |
Why?
|
Interferon-gamma | 1 | 2021 | 3206 | 0.110 |
Why?
|
Ileum | 1 | 1995 | 565 | 0.110 |
Why?
|
Sternum | 1 | 2013 | 177 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 2 | 2016 | 4042 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2020 | 990 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2018 | 2971 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1076 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2023 | 1917 | 0.100 |
Why?
|
Teaching | 2 | 2016 | 1174 | 0.100 |
Why?
|
Tracheobronchomegaly | 1 | 2011 | 5 | 0.100 |
Why?
|
Consensus | 1 | 2021 | 2959 | 0.100 |
Why?
|
Device Removal | 1 | 2016 | 656 | 0.100 |
Why?
|
Pilot Projects | 4 | 2021 | 8324 | 0.100 |
Why?
|
ras Proteins | 2 | 2013 | 1060 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2010 | 2016 | 0.100 |
Why?
|
Ultrasonography | 2 | 2018 | 5985 | 0.100 |
Why?
|
Cohort Studies | 6 | 2018 | 40561 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2158 | 0.100 |
Why?
|
Clinical Clerkship | 1 | 2016 | 532 | 0.100 |
Why?
|
Adaptive Immunity | 1 | 2016 | 713 | 0.090 |
Why?
|
Radiopharmaceuticals | 3 | 2010 | 2645 | 0.090 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1179 | 0.090 |
Why?
|
Antigens, CD | 1 | 2001 | 4026 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2013 | 367 | 0.090 |
Why?
|
Pneumothorax | 1 | 2014 | 379 | 0.090 |
Why?
|
Brucellosis | 1 | 2010 | 20 | 0.090 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 3843 | 0.090 |
Why?
|
Tracheostomy | 1 | 2014 | 401 | 0.090 |
Why?
|
Comorbidity | 2 | 2018 | 10388 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15076 | 0.090 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 388 | 0.090 |
Why?
|
Pneumonia | 2 | 2019 | 2133 | 0.090 |
Why?
|
Spirometry | 1 | 2013 | 864 | 0.090 |
Why?
|
Databases, Factual | 2 | 2016 | 7729 | 0.090 |
Why?
|
Guided Tissue Regeneration | 1 | 2010 | 85 | 0.090 |
Why?
|
Wound Healing | 2 | 2017 | 2785 | 0.090 |
Why?
|
Exercise Tolerance | 2 | 2011 | 770 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1425 | 0.080 |
Why?
|
Length of Stay | 3 | 2018 | 6309 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2001 | 4456 | 0.080 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2569 | 0.080 |
Why?
|
Emotions | 1 | 2020 | 2661 | 0.080 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2013 | 721 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7799 | 0.080 |
Why?
|
Respiratory Sounds | 1 | 2012 | 696 | 0.080 |
Why?
|
Cardiopulmonary Bypass | 1 | 2013 | 1066 | 0.080 |
Why?
|
Patient Care Team | 2 | 2017 | 2531 | 0.080 |
Why?
|
Tachycardia, Supraventricular | 1 | 2010 | 263 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.080 |
Why?
|
Patient Selection | 2 | 2020 | 4215 | 0.080 |
Why?
|
Tissue Engineering | 1 | 2018 | 1880 | 0.080 |
Why?
|
Nerve Block | 1 | 2014 | 644 | 0.080 |
Why?
|
Coated Materials, Biocompatible | 1 | 2010 | 319 | 0.080 |
Why?
|
Cause of Death | 1 | 2018 | 3584 | 0.080 |
Why?
|
Silicone Elastomers | 1 | 2007 | 84 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 1008 | 0.080 |
Why?
|
Animals | 14 | 2021 | 168757 | 0.080 |
Why?
|
Fibroblasts | 1 | 2018 | 4161 | 0.070 |
Why?
|
Biopsy, Fine-Needle | 2 | 2013 | 1094 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.070 |
Why?
|
Pulmonary Artery | 1 | 2016 | 1912 | 0.070 |
Why?
|
Dogs | 1 | 2012 | 3912 | 0.070 |
Why?
|
Adenoviridae | 2 | 2001 | 1099 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3527 | 0.070 |
Why?
|
Electromagnetic Phenomena | 1 | 2007 | 161 | 0.070 |
Why?
|
Rabbits | 3 | 2001 | 4894 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2021 | 13033 | 0.070 |
Why?
|
Ischemia | 1 | 1995 | 1907 | 0.070 |
Why?
|
Self Concept | 1 | 2012 | 1025 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2014 | 1364 | 0.070 |
Why?
|
Forced Expiratory Volume | 3 | 2019 | 1743 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12959 | 0.070 |
Why?
|
Gene Transfer Techniques | 2 | 2001 | 1224 | 0.070 |
Why?
|
Odds Ratio | 1 | 2018 | 9849 | 0.070 |
Why?
|
Computer-Aided Design | 2 | 2018 | 298 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2886 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9313 | 0.060 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2010 | 581 | 0.060 |
Why?
|
Mutation | 5 | 2016 | 29786 | 0.060 |
Why?
|
Risk Assessment | 4 | 2018 | 23338 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2018 | 3679 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7322 | 0.060 |
Why?
|
Lymphoma | 1 | 2013 | 1877 | 0.060 |
Why?
|
Prosthesis-Related Infections | 1 | 2010 | 538 | 0.060 |
Why?
|
Pain, Postoperative | 1 | 2014 | 1643 | 0.060 |
Why?
|
Echocardiography, Transesophageal | 1 | 2010 | 1133 | 0.060 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.060 |
Why?
|
Aortic Diseases | 1 | 2010 | 742 | 0.060 |
Why?
|
Prevalence | 2 | 2018 | 15226 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2849 | 0.060 |
Why?
|
Students, Medical | 1 | 2016 | 1862 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.060 |
Why?
|
Rats, Wistar | 2 | 2017 | 1901 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 5172 | 0.060 |
Why?
|
Survival Analysis | 2 | 2013 | 10252 | 0.060 |
Why?
|
Organizational Culture | 2 | 2017 | 510 | 0.060 |
Why?
|
Communication | 1 | 2017 | 3749 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2016 | 14722 | 0.050 |
Why?
|
Asthma | 2 | 2019 | 6011 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2282 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Nucleoside-Triphosphatase | 1 | 2001 | 19 | 0.050 |
Why?
|
Argon | 1 | 2021 | 36 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10638 | 0.050 |
Why?
|
Heart Neoplasms | 1 | 2005 | 374 | 0.050 |
Why?
|
Tidal Volume | 1 | 2023 | 490 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2015 | 12026 | 0.050 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2005 | 547 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9239 | 0.050 |
Why?
|
Transgenes | 2 | 2001 | 1009 | 0.050 |
Why?
|
Depression | 1 | 2020 | 7766 | 0.050 |
Why?
|
Prospective Studies | 6 | 2015 | 53288 | 0.040 |
Why?
|
Electrocoagulation | 1 | 2020 | 158 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2291 | 0.040 |
Why?
|
Vascular Patency | 1 | 2002 | 886 | 0.040 |
Why?
|
Critical Illness | 1 | 2012 | 2670 | 0.040 |
Why?
|
Surgical Instruments | 1 | 2002 | 395 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11366 | 0.040 |
Why?
|
Time Factors | 2 | 2016 | 40075 | 0.040 |
Why?
|
Smoking | 2 | 2013 | 8987 | 0.040 |
Why?
|
Apyrase | 1 | 2001 | 364 | 0.040 |
Why?
|
Surface Tension | 1 | 2018 | 47 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2001 | 549 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 390 | 0.040 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 3086 | 0.040 |
Why?
|
Lasers, Solid-State | 1 | 2020 | 169 | 0.040 |
Why?
|
Chest Tubes | 1 | 2018 | 150 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4034 | 0.040 |
Why?
|
Cough | 1 | 2021 | 555 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2010 | 3528 | 0.040 |
Why?
|
Veins | 1 | 2001 | 770 | 0.040 |
Why?
|
Critical Pathways | 1 | 2021 | 476 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 3923 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12245 | 0.040 |
Why?
|
Subcutaneous Tissue | 1 | 2017 | 135 | 0.040 |
Why?
|
Leg | 1 | 2002 | 1116 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2010 | 6234 | 0.040 |
Why?
|
Tensile Strength | 1 | 2017 | 335 | 0.030 |
Why?
|
Clinical Competence | 1 | 2012 | 4687 | 0.030 |
Why?
|
Sus scrofa | 1 | 2017 | 437 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1692 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2015 | 1850 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2023 | 1171 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 72290 | 0.030 |
Why?
|
Carcinoma | 1 | 2007 | 2375 | 0.030 |
Why?
|
3T3 Cells | 1 | 2017 | 1101 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2001 | 19229 | 0.030 |
Why?
|
Tissue Survival | 1 | 1995 | 118 | 0.030 |
Why?
|
Dependovirus | 1 | 2000 | 706 | 0.030 |
Why?
|
Blood Glucose | 1 | 2009 | 6256 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2001 | 1504 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2001 | 1198 | 0.030 |
Why?
|
Schools, Medical | 1 | 2021 | 880 | 0.030 |
Why?
|
Pressure | 1 | 2017 | 1203 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 2699 | 0.030 |
Why?
|
Delphi Technique | 1 | 2016 | 778 | 0.030 |
Why?
|
Professional Competence | 1 | 2017 | 447 | 0.030 |
Why?
|
Materials Testing | 1 | 2017 | 867 | 0.030 |
Why?
|
Sarcoma | 1 | 2005 | 1897 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 641 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2029 | 0.030 |
Why?
|
Anastomotic Leak | 1 | 2014 | 162 | 0.030 |
Why?
|
United States | 2 | 2018 | 69872 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17446 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2016 | 648 | 0.030 |
Why?
|
Registries | 3 | 2013 | 8089 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8949 | 0.030 |
Why?
|
Lung Injury | 1 | 2017 | 436 | 0.030 |
Why?
|
Focus Groups | 1 | 2016 | 1321 | 0.030 |
Why?
|
Carboplatin | 1 | 2015 | 801 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2010 | 18029 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2010 | 4776 | 0.030 |
Why?
|
Hospitals, University | 1 | 2013 | 571 | 0.020 |
Why?
|
Massachusetts | 2 | 2016 | 8663 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1915 | 0.020 |
Why?
|
Pleural Effusion | 1 | 2014 | 338 | 0.020 |
Why?
|
Connecticut | 1 | 2011 | 366 | 0.020 |
Why?
|
Curriculum | 2 | 2016 | 3605 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3313 | 0.020 |
Why?
|
Exudates and Transudates | 1 | 2011 | 172 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16689 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2000 | 3420 | 0.020 |
Why?
|
Learning Curve | 1 | 2012 | 208 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2274 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2013 | 1014 | 0.020 |
Why?
|
Social Behavior | 1 | 2016 | 1127 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2015 | 879 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
Biopsy | 2 | 2014 | 6756 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2010 | 364 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2250 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1842 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12951 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1643 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2013 | 6171 | 0.020 |
Why?
|
Selection Bias | 1 | 2010 | 371 | 0.020 |
Why?
|
North America | 1 | 2012 | 1249 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2016 | 1181 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1581 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8554 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 2682 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4851 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5882 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2618 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2649 | 0.020 |
Why?
|
Oncogenes | 1 | 2013 | 1265 | 0.020 |
Why?
|
Analgesics | 1 | 2014 | 1040 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4644 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3588 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2014 | 1486 | 0.020 |
Why?
|
Morbidity | 1 | 2011 | 1769 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1972 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1917 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2013 | 2480 | 0.020 |
Why?
|
Equipment Design | 1 | 2013 | 3582 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4186 | 0.020 |
Why?
|
Pain Measurement | 1 | 2014 | 3420 | 0.020 |
Why?
|
Pyridines | 1 | 2016 | 2825 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1995 | 3036 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8301 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 7023 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2728 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3558 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10481 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5720 | 0.010 |
Why?
|
Fractures, Bone | 1 | 2013 | 1947 | 0.010 |
Why?
|
Adolescent | 2 | 2023 | 85781 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18370 | 0.010 |
Why?
|
Chromium Radioisotopes | 1 | 2000 | 36 | 0.010 |
Why?
|
Chromogenic Compounds | 1 | 2000 | 30 | 0.010 |
Why?
|
Pharmaceutical Vehicles | 1 | 2000 | 59 | 0.010 |
Why?
|
Galactosides | 1 | 2000 | 52 | 0.010 |
Why?
|
Lac Operon | 1 | 2000 | 238 | 0.010 |
Why?
|
Graft Survival | 1 | 2010 | 3737 | 0.010 |
Why?
|
Pleural Neoplasms | 1 | 2005 | 607 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7279 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5535 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2005 | 1770 | 0.010 |
Why?
|
Mice | 2 | 2017 | 81183 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 2000 | 462 | 0.010 |
Why?
|
Tunica Intima | 1 | 2001 | 464 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2000 | 573 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12745 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6895 | 0.010 |
Why?
|
Mesothelioma | 1 | 2005 | 818 | 0.010 |
Why?
|
Rats | 1 | 1995 | 24260 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2010 | 3821 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2000 | 442 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2000 | 853 | 0.010 |
Why?
|
Electrocardiography | 1 | 2010 | 6442 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2000 | 1525 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2005 | 3479 | 0.010 |
Why?
|
Child | 1 | 2023 | 77709 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12354 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2000 | 2088 | 0.010 |
Why?
|
Genetic Markers | 1 | 2000 | 2634 | 0.010 |
Why?
|
Indoles | 1 | 2000 | 1839 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13695 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6365 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 13881 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.000 |
Why?
|